Phase II Clinical Trial of Stereotactic Ablative Radiotherapy (SABR) in Surgically Operable Stage I Non-Small Cell Lung Cancer (STARS)

被引：0
|
作者：
Chang, Joe Y. [1 ]
Mehran, Reza [2 ]
Balter, Peter [1 ]
Mcrae, Stephen [3 ]
Feng, Lei [4 ]
Berry, Donald [4 ]
Komaki, Ritsuko U. [1 ]
Roth, Jack [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Thorac Surg, Houston, AL USA
[3] Univ Texas MD Anderson Canc Ctr, Radiol, Houston, AL USA
[4] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, AL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
operable Stage I lung cancer; stereotactic radiotherapy; SBRT; SABR;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.02-032
引用
收藏
页码：S563 / S563
页数：1
相关论文
共 50 条
  • [1] Stereotactic Ablative Radiotherapy (SABR) in Potentially Operable Patients with Stage I Non-small Cell Lung Cancer
    Lagerwaard, F. J.
    Verstegen, N. E.
    Haasbeek, C. J. A.
    Slotman, B. J.
    Smit, E. F.
    Paul, M. A.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S79 - S80
  • [2] STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN POTENTIALLY OPERABLE STAGE I NON-SMALL CELL LUNG CANCER PATIENTS
    Lagerwaard, Frank J.
    Verstegen, Naomi E.
    Haasbeek, Cornelis J.
    Slotman, Ben
    Paul, M. A.
    Smit, Egbert F.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S278 - S279
  • [3] What is the role of stereotactic ablative radiotherapy in the management of surgically resectable and operable stage I non-small cell lung cancer?
    Love, Susannah M.
    Hardman, Gillian
    Mashar, Ruchir
    Shah, Rajesh D.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (05) : E483 - E486
  • [4] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [5] Is stereotactic ablative radiotherapy an alternative to surgery in operable stage I non-small cell lung cancer?
    Filippi, Andrea Riccardo
    Franco, Pierfrancesco
    Ricardi, Umberto
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2014, 19 (04) : 275 - 279
  • [6] Stereotactic radiotherapy for operable stage I non-small cell lung cancer
    Martin, E.
    Nicolet, C.
    Boisselier, P.
    Khalifa, J.
    Thureau, S.
    CANCER RADIOTHERAPIE, 2023, 27 (6-7): : 648 - 652
  • [7] Stereotactic ablative radiotherapy for operable stage I non-small cell lung cancer: not ready for prime time
    Connolly, James G.
    Jones, Gregory D.
    Caso, Raul
    Jones, David R.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [8] Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung Cancer
    Lagerwaard, Frank J.
    Verstegen, Naomi E.
    Haasbeek, Cornelis J. A.
    Slotman, Ben J.
    Paul, Marinus A.
    Smit, Egbert F.
    Senan, Suresh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (01): : 348 - 353
  • [9] Stereotactic ablative radiotherapy in combination with nivolumab for early stage operable non-small cell lung cancer: A phase II study
    Schvartsman, G.
    Amarato, Y.
    dos Santos, G. Prado
    Gomes, D. Bugano Diniz
    Koch, L. D. O.
    Bibas, B.
    Gomes, O., Jr.
    Campregher, P. Vidal
    Severino, P.
    Marti, L. Cavalheiro
    Ribeiro, V. Paes
    Leaden, L.
    Chate, R. Caruso
    de Campos, J. Ribas Milanez
    Sousa, V. A. Ramos
    Taranto, P.
    Moura, F. S.
    Terra, R. M.
    Rezende, A. C. P. D.
    Samano, M. Naoyuki
    ANNALS OF ONCOLOGY, 2024, 35 : S785 - S785
  • [10] Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)
    Islam, Mohammad
    Cyriac, Abby
    Durga, Tarun
    Sarkodie, Thomas
    Begum, Gulshad
    Evans, Joanne
    Palvai, Sreekanth
    Tun, Khin
    LUNG CANCER, 2023, 178 : S55 - S55
12345